Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
307 studies found for:    Open Studies | "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
21 Recruiting Empagliflozin and ACEi Effects on Hyperfiltration in Type 1 Diabetes (BETWEEN Study)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo (matching empagliflozin);   Drug: ramipril
22 Recruiting The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: G-Pen Mini™ (glucagon injection);   Other: Glucose Tabs;   Other: Basal Insulin Reduction
23 Recruiting Pancreas Volume in Preclinical Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: MRI, US, and blood samples
24 Recruiting Cross-sectional, Case Control Study of Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy
Condition: Diabetes Mellitus, Type 1
Interventions: Device: MRI including DTI , EEG, CGMS;   Behavioral: Neurocognitive tests
25 Recruiting Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Siltuximab
26 Recruiting Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.
Condition: Type 1 Diabetes Mellitus
Intervention:
27 Recruiting Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Behavioral: 'KnowIt';   Behavioral: 'OnTrack'
28 Recruiting Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
Condition: Type I Diabetes Mellitus
Interventions: Drug: Subetta;   Drug: Placebo
29 Recruiting A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Drug: Ladarixin;   Drug: Placebo
30 Recruiting Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Device: insulin pump to inControl AP platform
31 Not yet recruiting Gene-virus Interactions Implicated in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Genetic: Enterovirus vaccination
32 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Condition: Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
33 Recruiting Type 1 Diabetes Recurrence in Pancreas Transplants
Condition: Diabetes Mellitus, Type 1
Intervention:
34 Recruiting The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Saxagliptin;   Drug: Insulin
35 Recruiting A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ASP1941;   Drug: Placebo;   Other: Insulin Therapy
36 Recruiting Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Procedure: Islet graft;   Drug: best medical care
37 Recruiting Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Tauroursodeoxycholic Acid (TUDCA);   Drug: Sugar Pill (placebo)
38 Recruiting GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: GAD-Alum;   Drug: Vitamin D
39 Recruiting The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: Interventional arm-Mediterranean diet;   Other: Control Arm- regular nutritional instructions in accordance with the accepted nutritional guidelines
40 Recruiting Exploratory Study on Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.